Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease

Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Emphysema is an age-related and chronic inflammatory disease that is largely associated with exposure to cigarette smoke and is caused by a protease/antiprotease imbalance in the lungs. The identification of the cellular origin of the inflammatory mediators and the mechanisms underlying their expression and function is fundamental for gaining insight into the link between chronic inflammation and age-related lung disease. Senescent cells are characterized by irreversible cell cycle arrest. They remain metabolically active and are capable of secreting mediators of inflammation in vitro. Chronic exposure to cigarette smoke induces senescence of lung fibroblasts in mice, and hallmarks of senescence are found in lung fibroblasts of emphysema patients. Interestingly, our published data show that caveolin-1 promotes chronic cigarette smoke-induced senescence of lung fibroblasts in mice. To determine whether a causal relationship exists between caveolin-1-mediated senescence of lung fibroblasts and development of emphysema, we propose to test the novel paradigm that caveolin-1-mediated inhibition of autophagy promotes smoke-induced autophagy-to-senescence transition (AST) of lung fibroblasts, which become a chronic source of pro-inflammatory cytokines that stimulate the release of proteases by inflammatory cells, therefore contributing to the development of pulmonary emphysema. This central hypothesis will be tested by pursuing three specific aims: Aim 1: Determine the molecular mechanism of autophagy-to-senescence transition in lung fibroblasts. Hypothesis: caveolin-1 is a novel beclin-1-interacting protein. Caveolin-1 promotes cigarette smoke-induced AST of lung fibroblasts by inhibiting autophagy through disruption of the beclin-1/Vps34 complex. Aim 2: Identify the molecular mechanism and functional significance of the cigarette smoke-induced and caveolin-1-mediated chronic release of mediators of inflammation by senescent fibroblasts. Hypothesis: caveolin-1, through inhibition of eNOS activity, promotes the NF-kB-mediated sustained expression and secretion of cytokines by senescent fibroblasts that underwent AST, which stimulate the release of proteases by inflammatory cells. Aim 3: Determine if caveolin-1-mediated senescence of lung fibroblasts promotes chronic lung inflammation and emphysema in vivo. Hypothesis: chronic exposure to cigarette smoke induces senescence of lung fibroblasts, which promote chronic lung inflammation and contribute to the pathogenesis of emphysema in a caveolin-1-dependent fashion in vivo. These investigations will identify the caveolin-1-mediated switch from autophagic to senescent signaling as a novel biological process that is relevant to chronic lung inflammation and the pathogenesis of emphysema. Novel cellular and molecular mechanisms will be determined that have the potential to directly impact the future development of novel therapeutic interventions for the treatment of age-related lung disease.
 描述(由适用提供):肺气肿是一种与年龄相关的慢性炎症性疾病,主要与暴露于香烟烟雾有关,是由肺部蛋白酶/抗蛋白酶失衡引起的。鉴定细胞来源 炎症介质以及其表达和功能的基础机制对于洞悉慢性炎症与与年龄相关的肺部疾病之间的联系至关重要。衰老细胞的特征是不可逆的细胞周期停滞。它们保持代谢活跃,能够在体外分泌炎症介质。长期暴露于香烟烟雾会引起小鼠肺成纤维细胞的感受,并且在肺气肿患者的肺成纤维细胞中发现了感应标志。有趣的是,我们发表的数据表明,小鼠1促进了小鼠肺成纤维细胞的慢性烟雾诱导的感应。为了确定小窝蛋白1介导的肺成纤维细胞的敏感和肺气肿的发展,我们建议测试新的范式,即小窝蛋白1介导的自噬抑制抑制烟雾引起的烟雾诱导的自噬 - 渗透到味道过渡(AST),通过肺成纤维细胞的释放,这是一个繁殖的刺激,这是一个繁殖的刺激,这是一个模仿刺激的刺激性,这是一个繁殖的刺激性的,这是一个繁殖的刺激性的刺激性,该刺激的刺激性刺激了刺激性的刺激性。细胞,因此有助于肺肺气肿的发展。该中心假设将通过追求三个特定目的来检验:目标1:确定肺成纤维细胞中自噬至味道转变的分子机制。假设:小窝蛋白-1是一种新型的Beclin-1相互作用蛋白。 Caveolin-1通过破坏Beclin-1/VPS34复合物来抑制自噬,从而促进肺成纤维细胞的烟雾引起的AST。 AIM 2:确定香烟烟雾诱导的和小窝蛋白-1介导的慢性炎症介体炎症的慢性释放的分子机制和功能意义。假设:小窝蛋白1通过抑制eNOS活性,促进了通过经历AST的感觉成纤维细胞对NF-KB介导的持续表达和细胞因子分泌,从而刺激炎性细胞释放蛋白酶。 AIM 3:确定小窝蛋白-1介导的肺成纤维细胞的感应是否促进了慢性肺部感染和体内肺气肿。假设:长期暴露于香烟烟雾会诱导肺成纤维细胞的感应,从而促进慢性肺部感染并在体内依赖caveolin-1依赖性时尚肺气肿的发病机理。这些研究将确定可爱素1介导的从自噬到感觉信号传导的切换,是一种与慢性肺部感染和肺气肿的发病机理有关的新生物学过程。将确定新型的细胞和分子机制,这些机制具有直接影响新型治疗干预措施以治疗与年龄相关的肺部疾病的未来发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

FERRUCCIO GALBIAT...的其他基金

Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9305499
    9305499
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9459856
    9459856
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9899946
    9899946
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    9059176
    9059176
  • 财政年份:
    2015
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin-1-mediated senescence, chronic inflammation and age-related lung disease
Caveolin-1介导的衰老、慢性炎症和年龄相关性肺部疾病
  • 批准号:
    8903586
    8903586
  • 财政年份:
    2014
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8507585
    8507585
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8114097
    8114097
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    8301580
    8301580
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7903303
    7903303
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathway
Caveolin 1:PP2A/ATM/p53 通路的新型调节剂
  • 批准号:
    7574065
    7574065
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:

相似国自然基金

基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
  • 批准号:
    32330014
  • 批准年份:
    2023
  • 资助金额:
    215 万元
  • 项目类别:
    重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
  • 批准号:
    72303209
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
  • 批准号:
    32370477
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
  • 批准号:
    32371605
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
  • 批准号:
    42306159
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6
顺铂化疗中通过阻断 HDAC6 拯救肾脏
  • 批准号:
    10841270
    10841270
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
MRI Study of Hydrogen Water and Minocycline Combination Therapy for Ischemic Stroke
氢水与米诺环素联合治疗缺血性中风的MRI研究
  • 批准号:
    10564735
    10564735
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
  • 批准号:
    10639102
    10639102
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Apelin Signaling in Muscle Regeneration
肌肉再生中的 Apelin 信号转导
  • 批准号:
    10557030
    10557030
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别:
Cellular rejuvenation during oogenesis
卵子发生过程中的细胞再生
  • 批准号:
    10864188
    10864188
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
    $ 38.5万
  • 项目类别: